The interests of our research group span the disciplines of organic synthesis, asymmetric catalysis, peptide drug design computational chemistry and pharmacology. Current projects are:
• Synthesis and evaluation of inhibitors targeting HIV and TB
• Synthesis of classes of chiral ligands and catalysts
• Experimental and theoretical research about the fundamental aspects of peptide folding.
• Various computational projects into mechanistic effects of our synthetic projects.
